Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Hanover - Delayed Quote EUR

Verona Pharma PLC (I9SA.HA)

Compare
51.80
+0.40
+(0.78%)
At close: April 15 at 5:25:12 PM GMT+2
Loading Chart for I9SA.HA
  • Previous Close 51.40
  • Open 0.00
  • Bid --
  • Ask --
  • Day's Range 0.00 - 0.00
  • 52 Week Range 0.00 - 66.00
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Apr 29, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: I9SA.HA

View More

Performance Overview: I9SA.HA

Trailing total returns as of 4/16/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

I9SA.HA
18.26%
MSCI WORLD (^990100-USD-STRD)
5.03%

1-Year Return

I9SA.HA
252.38%
MSCI WORLD (^990100-USD-STRD)
6.80%

3-Year Return

I9SA.HA
1,285.03%
MSCI WORLD (^990100-USD-STRD)
18.94%

5-Year Return

I9SA.HA
869.86%
MSCI WORLD (^990100-USD-STRD)
79.26%

Compare To: I9SA.HA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: I9SA.HA

View More

Valuation Measures

Annual
As of 4/14/2025
  • Market Cap

    4.37B

  • Enterprise Value

    4.13B

  • Trailing P/E

    --

  • Forward P/E

    384.62

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    112.43

  • Price/Book (mrq)

    24.23

  • Enterprise Value/Revenue

    110.67

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: I9SA.HA

View More

Company Insights: I9SA.HA

Research Reports: I9SA.HA

View More